Lomitapide

Contraindicated

Lomitapide Ketoconazole Topical Extina® Foam Increased lomitapide exposure Details Lomitapide Lefamulin Xenleta Increased lomitapide exposure Details Lomitapide Lenacapavir Injection Sunlenca Increased lomitapide exposure Details Lomitapide Lenacapavir Oral Sunlenca Increased lomitapide exposure Details Lomitapide Letermovir Injection Prevymis Increased lomitapide exposure Details

Major

Lomitapide Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Lomitapide Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Lomitapide Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine-related toxicity Details Lomitapide Simvastatin Flolipid Explained Increased simvastatin exposure and an increased risk of myopathy and rhabdomyolysis Details Lomitapide Asciminib Scemblix Increased lomitapide exposure and an increased risk of lomitapide-related adverse reactions Details Lomitapide Azithromycin AzaSite Increased lomitapide exposure Details Lomitapide Belumosudil Rezurock Explained Increased lomitapide exposure Details Lomitapide Bicalutamide Casodex Increased lomitapide exposure Details Lomitapide Atorvastatin Atorvaliq Increased lomitapide exposure Details Lomitapide Amlodipine Amvaz® Increased lomitapide exposure Details Lomitapide Bedaquiline Sirturo Increased bedaquiline exposure Details Lomitapide Brodalumab Injection Siliq Increased lomitapide exposure Details Lomitapide Budesonide Entocort Increased budesonide exposure Details Lomitapide Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Lomitapide Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Lomitapide Cholestyramine Resin Locholest® Reduced lomitapide exposure Details Lomitapide Clotrimazole Aardora Anti-Fungal Maximum Strength Increased lomitapide exposure Details Lomitapide Clotrimazole Lozenge Mycelex® Increased lomitapide exposure Details Lomitapide Clotrimazole Topical Cruex Antifungal Increased lomitapide exposure Details Lomitapide Clotrimazole Vaginal Gyne-Lotrimin 3® Cream Increased lomitapide exposure Details Lomitapide Colesevelam Welchol Reduced lomitapide exposure Details Lomitapide Colestipol Colestid Reduced lomitapide exposure Details Lomitapide Cyclosporine Injection Atopica Increased lomitapide exposure and an increased P-gp substrate exposure Details Lomitapide Cyclosporine Ophthalmic Cequa Increased lomitapide exposure and an increased P-gp substrate exposure Details Lomitapide Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Lomitapide Enasidenib Idhifa Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Lomitapide Encorafenib Braftovi Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Lomitapide Entrectinib Rozlytrek Increased lomitapide exposure Details Lomitapide Erdafitinib Balversa Increased lomitapide exposure Details Lomitapide Esketamine Nasal Spray Spravato Increased lomitapide exposure Details Lomitapide Esomeprazole Nexium Increased lomitapide exposure Details Lomitapide Esomeprazole Injection Nexium Increased lomitapide exposure Details Lomitapide Estradiol Delestrogen Increased lomitapide exposure Details Lomitapide Estradiol Topical Divigel Increased lomitapide exposure Details Lomitapide Estradiol Transdermal Patch Alora® Increased lomitapide exposure Details